深圳万和制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
12
NMPA:12
Drug Approvals
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20253371
- Approval Date
- Feb 11, 2025
NMPA
Polyethylene Glycol Electrolytes Powder(III)
- Product Name
- 复方聚乙二醇电解质散(Ⅲ)
- Approval Number
- 国药准字H20244052
- Approval Date
- Jun 18, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20243354
- Approval Date
- Mar 19, 2024
NMPA
Polyethylene Glycol Electrolytes Powder（Ⅱ）
- Product Name
- 和爽
- Approval Number
- 国药准字H20030827
- Approval Date
- Feb 2, 2024
NMPA
Polyethylene Glycol Electrolytes Powder（Ⅱ）
- Product Name
- 和爽
- Approval Number
- 国药准字H20030828
- Approval Date
- Feb 2, 2024
NMPA
Erythromycin Enteric Capsules
- Product Name
- 新红康
- Approval Number
- 国药准字H10970170
- Approval Date
- Feb 2, 2024
NMPA
Erythromycin Enteric Capsules
- Product Name
- 新红康
- Approval Number
- 国药准字H19990267
- Approval Date
- Feb 2, 2024
NMPA
Tamsulosin Hydrochloride Sustained-release Capsules
- Product Name
- 盐酸坦索罗辛缓释胶囊
- Approval Number
- 国药准字H20223698
- Approval Date
- Sep 30, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found